Statistics · Trade Marks Journal
Indian trademark filing statistics
Journal No. 2285, dated 2 Nov 2026, advertised 6,993 trademarks. Over the last 12 journals that is 76,153 marks, about 6,346 a week; 64.7% for goods (classes 1–34) and 35.3% for services (35–45).
Source: the weekly Trade Marks Journal published by the Trade Marks Registry, as recorded by TrademarkVista. Updated with each new journal.
Most-filed classes
Recent journals
| Journal | Date | Marks advertised | Top class | Last date to oppose |
|---|---|---|---|---|
| No. 2285 | 2 Nov 2026 | 6,993 | Class 5 (Pharmaceuticals) | 2 Mar 2027 |
| No. 2284 | 26 Oct 2026 | 5,828 | Class 5 (Pharmaceuticals) | 26 Feb 2027 |
| No. 2283 | 19 Oct 2026 | 11,128 | Class 5 (Pharmaceuticals) | 19 Feb 2027 |
| No. 2282 | 12 Oct 2026 | 5,322 | Class 5 (Pharmaceuticals) | 12 Feb 2027 |
| No. 2281 | 5 Oct 2026 | 6,217 | Class 5 (Pharmaceuticals) | 5 Feb 2027 |
| No. 2280 | 28 Sep 2026 | 4,476 | Class 35 (Retail, advertising, business) | 28 Jan 2027 |
| No. 2279 | 21 Sep 2026 | 6,134 | Class 5 (Pharmaceuticals) | 21 Jan 2027 |
| No. 2278 | 14 Sep 2026 | 5,439 | Class 5 (Pharmaceuticals) | 14 Jan 2027 |
| No. 2277 | 7 Sep 2026 | 4,803 | Class 5 (Pharmaceuticals) | 7 Jan 2027 |
| No. 2276 | 31 Aug 2026 | 6,692 | Class 5 (Pharmaceuticals) | 31 Dec 2026 |
| No. 2275 | 24 Aug 2026 | 6,707 | Class 5 (Pharmaceuticals) | 24 Dec 2026 |
| No. 2274 | 17 Aug 2026 | 6,414 | Class 5 (Pharmaceuticals) | 17 Dec 2026 |
Questions
How many trademarks are advertised in the Trade Marks Journal each week?
Over the last 12 journals recorded here, an average of 6,346 marks per journal (latest: Journal No. 2285, 6,993 marks).
Which trademark class is filed most in India?
In the last 12 journals, Class 5 (Pharmaceuticals) had the most advertised marks: 11.1% of all marks, followed by Class 35 (Retail, advertising, business) at 9.9%.
How long do I have to oppose a mark in the Journal?
4 months from the date of the journal in which it is advertised. Each journal's last date to oppose is listed in the table above.